Nanog binds directly to the enhancer region of the BNIP3L (BCL2 Interacting Protein 3 Like) promoter during hypoxia, thereby releasing BECLIN from Bcl-2 (B-cell lymphoma 2), increasing its expression, and promoting one of the hypoxia-induced responses of cancer cells [141,166]. Here, NANOG is linked to cancer.